Market Cap 235.53M
Revenue (ttm) 194.06M
Net Income (ttm) 14.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 7.39%
Debt to Equity Ratio 0.00
Volume 1,656,700
Avg Vol 1,041,812
Day's Range N/A - N/A
Shares Out 48.36M
Stochastic %K 81%
Beta 1.99
Analysts Strong Sell
Price Target $9.88

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services
Sector: Healthcare
Phone: 866 351 5907
Website: lifemd.com
Address:
236 Fifth Avenue, Suite 400, New York, United States
StockScanners
StockScanners Jul. 4 at 5:11 PM
$LFMD keep watch if this holds above 4.77
0 · Reply
Alex1965
Alex1965 Jul. 2 at 8:16 PM
$LFMD The stock got dumped for days and under $4.00 to July 1st. Now why ??? Think smart money, funds.... Nonsense and baseless comments like this one confuse the less savvy retail investors... Beware !!! "...this stock feels more like it is being bleed to death than actually trying to grow and become profitable now." All LFMD's fundamental metrics are all fine and historic best except revenue growth. And that too will improve markedly over the next 18 months starting in Q3 this year. Remember to perform your own DD. PS New exclusive deals getting signed before calendar year ends. a Stronger moat and a very different business model from the rest of the peers.
0 · Reply
prismmarketview
prismmarketview Jul. 2 at 4:11 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today’s Leaders. Allurion Technologies Inc. (OTC: $ALUR) is ripping higher again today, with the stock up about 36%to 4.00 from a prior close of 2.94. Chemomab Therapeutics Ltd. (NASDAQ: $CMMB ) is having a strong session, with the stock up about 32% to 2.2401 from a prior close of 1.70. Other Notable Movers: DarioHealth Corp. ($DRIO ) up 13% LifeMD inc. ( $LFMD ) up 10% Aspira Women’s Health ( $AWH) down -15% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders-2/
0 · Reply
Alex1965
Alex1965 Jul. 2 at 1:53 PM
$LFMD Where is it going so fast ???
0 · Reply
Alex1965
Alex1965 Jul. 1 at 3:45 PM
$LFMD https://www.lilly.com/lillydirect/medicare#overview
0 · Reply
ClarissaLove
ClarissaLove Jul. 1 at 7:13 AM
$LFMD I bet you’re good at picking stocks that require lots and lots of “patience.”
0 · Reply
MarioAndretti
MarioAndretti Jun. 30 at 12:56 AM
$LFMD impatient fucks
2 · Reply
thejman1
thejman1 Jun. 29 at 2:56 PM
$LFMD this stock feels more like it is being bleed to death than actually trying to grow and become profitable now.
0 · Reply
Alex1965
Alex1965 Jun. 28 at 3:21 AM
$LFMD https://seekingalpha.com/news/4607683-medicare-glp-1-bridge-what-to-expect?utm_content=link-3&position=rta_news_sublogic_pretestlaunch_main_2_textlink&utm_source=seeking_alpha&utm_campaign=rta-stock-news&messageid=2900&mailingid=46328155&serial=46328155.3339&utm_term=46328155.3339&source=email_2900&utm_medium=email
0 · Reply
IndependentWatch5
IndependentWatch5 Jun. 26 at 8:07 PM
$LFMD this has been an awful buy
1 · Reply
Latest News on LFMD
LifeMD appoints Umesh Sripad as chief technology officer

2026-06-01T14:34:47.000Z - 4 weeks ago

LifeMD appoints Umesh Sripad as chief technology officer


LifeMD Appoints Umesh Sripad as Chief Technology Officer

Jun 1, 2026, 8:05 AM EDT - 4 weeks ago

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LFMDP


LifeMD Transcript: 16th Annual LD Micro Invitational Conference

May 19, 2026, 12:00 PM EDT - 6 weeks ago

LifeMD Transcript: 16th Annual LD Micro Invitational Conference


LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026, 8:00 AM EDT - 7 weeks ago

LifeMD to Participate in Upcoming Investor Conferences

LFMDP


LifeMD Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 2 months ago

LifeMD Slides: Investor presentation


LifeMD reports Q1 EPS (20c), consensus (12c)

2026-05-07T00:47:06.000Z - 2 months ago

LifeMD reports Q1 EPS (20c), consensus (12c)


LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M

2026-05-07T00:46:21.000Z - 2 months ago

LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M


LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M

2026-05-07T00:45:57.000Z - 2 months ago

LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M


LifeMD Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Earnings Call Transcript: Q1 2026


LifeMD Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Earnings release: Q1 2026


LifeMD Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Slides: Q1 2026


LifeMD Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Quarterly report: Q1 2026


LifeMD Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 2 months ago

LifeMD Reports First Quarter 2026 Results


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD management to meet with BTIG

2026-04-24T17:05:27.000Z - 2 months ago

LifeMD management to meet with BTIG


LifeMD now offering Foundayo from Eli Lilly

2026-04-10T12:26:19.000Z - 3 months ago

LifeMD now offering Foundayo from Eli Lilly

LLY


LifeMD announces launch of Wegovy subscription program

2026-03-31T14:25:15.000Z - 3 months ago

LifeMD announces launch of Wegovy subscription program

NVO


LifeMD management to meet virtually with B. Riley

2026-03-17T15:41:34.000Z - 3 months ago

LifeMD management to meet virtually with B. Riley


LifeMD upgraded to Outperform from Neutral at Mizuho

2026-03-16T08:40:05.000Z - 3 months ago

LifeMD upgraded to Outperform from Neutral at Mizuho


LifeMD price target raised to $10 from $8 at Freedom Capital

2026-03-12T14:11:07.000Z - 4 months ago

LifeMD price target raised to $10 from $8 at Freedom Capital


LifeMD price target raised to $10 from $9 at H.C. Wainwright

2026-03-11T10:15:39.000Z - 4 months ago

LifeMD price target raised to $10 from $9 at H.C. Wainwright


LifeMD Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Earnings Call Transcript: Q4 2025


LifeMD Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Annual report: Q4 2025


LifeMD Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Earnings release: Q4 2025


LifeMD Slides: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Slides: Q4 2025


LifeMD reports Q4 EPS 41c, consensus 3c

2026-03-09T20:21:55.000Z - 4 months ago

LifeMD reports Q4 EPS 41c, consensus 3c


LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M

2026-03-09T20:21:26.000Z - 4 months ago

LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M


LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M

2026-03-09T20:20:41.000Z - 4 months ago

LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M


LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mar 9, 2026, 4:05 PM EDT - 4 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMDP


LifeMD closes $50M revolving credit facility

2026-01-06T13:47:34.000Z - 6 months ago

LifeMD closes $50M revolving credit facility


LifeMD Earnings Call Transcript: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Earnings Call Transcript: Q3 2025


LifeMD Quarterly report: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Quarterly report: Q3 2025


LifeMD Earnings release: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Earnings release: Q3 2025


LifeMD Slides: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Slides: Q3 2025


LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 8 months ago

LifeMD Reports Third Quarter 2025 Results

LFMDP


LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 8 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMDP


StockScanners
StockScanners Jul. 4 at 5:11 PM
$LFMD keep watch if this holds above 4.77
0 · Reply
Alex1965
Alex1965 Jul. 2 at 8:16 PM
$LFMD The stock got dumped for days and under $4.00 to July 1st. Now why ??? Think smart money, funds.... Nonsense and baseless comments like this one confuse the less savvy retail investors... Beware !!! "...this stock feels more like it is being bleed to death than actually trying to grow and become profitable now." All LFMD's fundamental metrics are all fine and historic best except revenue growth. And that too will improve markedly over the next 18 months starting in Q3 this year. Remember to perform your own DD. PS New exclusive deals getting signed before calendar year ends. a Stronger moat and a very different business model from the rest of the peers.
0 · Reply
prismmarketview
prismmarketview Jul. 2 at 4:11 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today’s Leaders. Allurion Technologies Inc. (OTC: $ALUR) is ripping higher again today, with the stock up about 36%to 4.00 from a prior close of 2.94. Chemomab Therapeutics Ltd. (NASDAQ: $CMMB ) is having a strong session, with the stock up about 32% to 2.2401 from a prior close of 1.70. Other Notable Movers: DarioHealth Corp. ($DRIO ) up 13% LifeMD inc. ( $LFMD ) up 10% Aspira Women’s Health ( $AWH) down -15% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders-2/
0 · Reply
Alex1965
Alex1965 Jul. 2 at 1:53 PM
$LFMD Where is it going so fast ???
0 · Reply
Alex1965
Alex1965 Jul. 1 at 3:45 PM
$LFMD https://www.lilly.com/lillydirect/medicare#overview
0 · Reply
ClarissaLove
ClarissaLove Jul. 1 at 7:13 AM
$LFMD I bet you’re good at picking stocks that require lots and lots of “patience.”
0 · Reply
MarioAndretti
MarioAndretti Jun. 30 at 12:56 AM
$LFMD impatient fucks
2 · Reply
thejman1
thejman1 Jun. 29 at 2:56 PM
$LFMD this stock feels more like it is being bleed to death than actually trying to grow and become profitable now.
0 · Reply
Alex1965
Alex1965 Jun. 28 at 3:21 AM
$LFMD https://seekingalpha.com/news/4607683-medicare-glp-1-bridge-what-to-expect?utm_content=link-3&position=rta_news_sublogic_pretestlaunch_main_2_textlink&utm_source=seeking_alpha&utm_campaign=rta-stock-news&messageid=2900&mailingid=46328155&serial=46328155.3339&utm_term=46328155.3339&source=email_2900&utm_medium=email
0 · Reply
IndependentWatch5
IndependentWatch5 Jun. 26 at 8:07 PM
$LFMD this has been an awful buy
1 · Reply
Phil1973
Phil1973 Jun. 26 at 7:33 PM
$LFMD this is now a 100% “show me” stock. Won’t trade on press releases and hope - just actual results.
1 · Reply
alphawolftrading
alphawolftrading Jun. 23 at 10:21 PM
$LFMD I just sat down again with LifeMD (NASDAQ: LFMD) Co‑Founder & CEO Justin Schreiber for a deep dive into how they’re building a full‑stack virtual healthcare and pharmacy platform – not just a GLP‑1 story. We cover their revamped leadership team, the LifeMD+ $19/month membership model for 24/7 primary and urgent care, upcoming Medicare GLP‑1 access at a $50 copay, and how AI, women’s and men’s health, metabolic programs, and personalized compounding fit into LifeMD’s next phase of growth. https://youtu.be/SfvC-JAFO4M
3 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 9:36 PM
$LFMD Back to the 3s like it never left. Does anyone here have a legitimate bull case that they can kindly share ?
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 2:09 PM
0 · Reply
Annaba514
Annaba514 Jun. 18 at 5:50 PM
$LFMD always when HIMS goes up LFMD get destroyed. Weird.
1 · Reply
ClarissaLove
ClarissaLove Jun. 18 at 1:13 PM
$LFMD LifeMD is unraveling on two fronts: web traffic -55% y/y, and the app rank tumbled to #227 this week
0 · Reply
TaoistTrader
TaoistTrader Jun. 15 at 5:50 PM
$LFMD it’s that time of year for a break out
1 · Reply
Annaba514
Annaba514 Jun. 12 at 2:36 PM
$LFMD RUSSEL has moved up by 4% in 2 day however this thing didn't follow..
0 · Reply
Alex1965
Alex1965 Jun. 11 at 3:43 PM
$LFMD Another failed dump...
0 · Reply
Alex1965
Alex1965 Jun. 10 at 5:39 PM
$LFMD It's back up on very low volume with the broad market down for 2 days. So what's up ? $5.50 - .75 next leg up ?? A couple of new developments pending near term. Monthly website visits are back up for the past 2 months, 28 and 24% respectively. But don't mind me , I'm just a pumper with a huge position on this stock. What I see as worst case scenario for Q2 is: 1. Revenue guidance met closer to the upper range or better. 2. Adj. EBITDA break even or close. 3. Positive Oper. cash flow of $2.5 to $3.0M 4. Minimum revenue guidance for Q3 of $54 to $56M. But what do I know right ??? GL and perform your own DD Long LFMD
1 · Reply
MarioAndretti
MarioAndretti Jun. 8 at 11:28 PM
$LFMD SLOW action but we should be trading at 8-9 by EOY
1 · Reply
StockPitcher
StockPitcher Jun. 8 at 8:42 PM
$LFMD Selling some covered calls at $7 for the July expiration date. The lack of growth is troubling me, I’m not as bullish as I once was
1 · Reply